# Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV

> **NCT06978621** · PHASE3 · RECRUITING · sponsor: **Chiang Mai University** · enrollment: 36 (estimated)

## Conditions studied

- Hepatitis A
- Hepatitis A Virus
- Vaccine-Preventable Diseases

## Interventions

- **BIOLOGICAL:** Inactivated hepatitis A vaccine (I-HAV)

## Key facts

- **NCT ID:** NCT06978621
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-25
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-09-30
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06978621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06978621, "Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06978621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*